Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2014 Q2- Text added to 2014 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
New words:
accomplish, aim, antiviral, ATHENA, Australia, Canada, characterize, cohort, Comparison, cure, DAA, Deutschland, Europe, excluded, filtration, Food, Glaxo, glomerular, group, inhibitor, light, microMarkersSM, minute, older, OLYSIO, pharmacokinetic, placebo, protease, quantification, relapse, simeprevir, subsidiary, underwritten, virologic
Removed:
background, biomarker, commence, longitudinal, prevention, purpose, sample, severalmicroRNA, signature, strong, tomicroRNA, utilize
Valuein 2014 Q2 filing- Value in 2014 Q3 filing
Original filings
Filing view